Can the healthy brain offer clues to curing Alzheimer's? Management of migraine in children and adolescentsMany therapies effective in adults have not been adequately studied in children. Ocrevus receives conditional approval for use in early primary progressive MS Intravenous monoclonal antibody originally approved only for use in relapsing remitting multiple sclerosis (MS) CGRP antagonists: new migraine prevention therapies in current development Monoclonal antibodies targeting the calcitonin gene-related peptide pathway are under study for preventing episodic and chronic migraine Outcomes in newly diagnosed epilepsy have not improved over the past 20 years Despite availability of newer drugs, epilepsy still uncontrolled in more than one-third of patients New autism research centre to be created thanks to $16M donation Hints that lifestyle changes might guard against dementia No benefit from long-term opioid therapy for patients with polyneuropathy Increased risk of depression, opioid dependence and opioid overdose, without any improvement in functional status Antibiotic fends off MS Long-term daily ASA use linked to higher-than-expected risk of bleeding in over 75s Authors conclude that proton-pump inhibitors should be co-prescribed in this age group First Previous 31 32 33 34 35 Next Last
